Anlon Healthcare Board Meeting on July 30, 2026

Anlon Healthcare Ltd has scheduled a Board of Directors meeting for July 30, 2026. The agenda includes approving the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, along with a limited review by auditors. Additionally, the board will consider authorizing the Chairman & Managing Director and Whole Time Director to enter into a share swap arrangement for acquiring stakes in Apiqo Organics Private Limited and Bizotic LifeScience Private Limited, aiming to make them wholly-owned subsidiaries through preferential allotment of equity shares.